LEXEO THERAPEUTICS, INC. COMMON STOCK

NASDAQ: LXEO (Lexeo Therapeutics, Inc.)

Last update: 3 days ago, 9:00PM

4.24

0.32 (8.16%)

Previous Close 3.92
Open 3.88
Volume 423,344
Avg. Volume (3M) 1,041,977
Market Cap 140,733,648
Price / Book 1.60
52 Weeks Range
1.45 (-65%) — 19.50 (359%)
Earnings Date 11 Aug 2025
Diluted EPS (TTM) -3.31
Total Debt/Equity (MRQ) 10.67%
Current Ratio (MRQ) 3.41
Operating Cash Flow (TTM) -88.00 M
Levered Free Cash Flow (TTM) -50.43 M
Return on Assets (TTM) -42.89%
Return on Equity (TTM) -80.65%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Lexeo Therapeutics, Inc. Bearish Bearish

AIStockmoo Score

0.0
Analyst Consensus 1.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages -1.0
Technical Oscillators 2.0
Average 0.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
LXEO 141 M - - 1.60
ASND 11 B - - -
CNTA 2 B - - 4.36
GYRE 725 M - 401.50 11.27
BCAX 631 M - - 1.37
DNTH 561 M - - 1.77

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 0.75%
% Held by Institutions 121.11%

Ownership

Name Date Shares Held
D1 Capital Partners L.P. 31 Mar 2025 978,652
Avidity Partners Management Lp 31 Mar 2025 645,000
52 Weeks Range
1.45 (-65%) — 19.50 (359%)
Price Target Range
10.00 (135%) — 20.00 (371%)
High 20.00 (Chardan Capital, 371.70%) Buy
20.00 (RBC Capital, 371.70%) Buy
Median 18.00 (324.53%)
Low 10.00 (JP Morgan, 135.85%) Buy
Average 16.60 (291.51%)
Total 5 Buy
Avg. Price @ Call 3.46
Firm Date Target Price Call Price @ Call
JP Morgan 30 May 2025 10.00 (135.85%) Buy 2.72
HC Wainwright & Co. 16 May 2025 15.00 (253.77%) Buy 3.24
08 Apr 2025 23.00 (442.45%) Buy 1.82
Chardan Capital 13 May 2025 20.00 (371.70%) Buy 2.83
08 Apr 2025 22.00 (418.87%) Buy 1.82
RBC Capital 25 Mar 2025 20.00 (371.70%) Buy 4.44
Leerink Partners 24 Mar 2025 18.00 (324.53%) Buy 4.09

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria